Solid cancer
Conditions
Interventions
None listed
Sponsors
Kyoto University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients with solid tumors who have undergone or are scheduled to undergo cancer chemotherapy. (2) Individuals who are 18 years of age or older at the time of obtaining consent. (3) Patients from whom at least one of the following types of tissue can be obtained: A. Tumor tissue Surplus biopsy or surgical specimens from patients treated at Kyoto University Hospital. B. Normal tissue Surplus biopsy or surgical specimens from patients treated at Kyoto University Hospital. Surplus specimens from patients treated at Kyoto University Hospital. Peripheral blood samples (20 mL) collected in addition to routine blood draws during regular clinical care. Newly collected oral mucosal samples (oral swab) and saliva obtained specifically for this study. C. Samples (biopsy specimens, surgical specimens, peripheral blood) from patients who have consented to the Clinical BioResource Center, Kyoto University Hospital's information document "Information on the Storage and Future Research Use of Biological Samples (approved by the Medical Faculty Council)."
Exclusion criteria
Exclusion criteria: Patients deemed unsuitable as research participants at the discretion of the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection rate of actionable genomic alterations | — |
Countries
Japan
Contacts
Public ContactTomohiro Kondo
Kyoto University Hospital Clinical Oncology
Outcome results
None listed